|
1
|
Campanacci M: Bone and soft tissue
tumours. New York: Springer-Verlag; pp. 199–232. 1999
|
|
2
|
Weeden S, Grimer RJ, Cannon SR, Taminiau
AH and Uscinska BM: European Osteosarcoma, Intergroup: The effect
of local recurrence on survival in resected osteosarcoma. Eur J
Cancer. 37:39–46. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Marulanda GA, Henderson ER, Johnson DA,
Letson GD and Cheong D: Orthopaedic surgery options for the
treatment of primary osteosarcoma. Cancer Control. 15:13–20. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Grimer RJ, Taminiau AM and Cannon SR:
Surgical Subcommitte of the European Osteosarcoma Intergroup:
Surgical outcomes in osteosarcoma. J Bone Joint Surg Br.
84:395–400. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bradley CJ, Yabroff KR, Dahman B, Feuer
EJ, Mariotto A and Brown ML: Productivity costs of cancer mortality
in the United States: 2000–2020. J Natl Cancer Inst. 100:1763–1770.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kransdorf MJ and Murphey MD: Radiologic
evaluation of soft-tissue masses: A current perspective. AJR Am J
Roentgenol. 175:575–587. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Siegel MJ: Magnetic resonance imaging of
musculoskeletal soft tissue masses. Radiol Clin North Am.
39:701–720. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang CK, Li CW, Hsieh TJ, Chien SH, Liu GC
and Tsai KB: Characteriztion of bone and soft tissue tumors with in
vivo 1H-MR spectroscopy: Initial results. Radiology. 232:599–605.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Johansen R, Jensen LR, Rydland J, Goa PE,
Kvistad KA, Bathen TF, Axelson DE, Lundgren S and Gribbestad IS:
Predicting survival and early clinical response to primary
chemotherapy for patients with locally advanced breast cancer using
DCE-MRI. J Magn Reson Imaging. 29:1300–1307. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu Q, Hu T, He L, Huang X, Tian X, Zhang
H, He L, Pu W, Zhang L, Sun H, et al: Genetic targeting of
sprouting angiogenesis using Apln-CreER. Nat Commun. 6:60202015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fukumura D and Jain RK: Imaging
angiogenesis and the microenvironment. APMIS. 116:695–715. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rak JW, St Croix BD and Kerbel RS:
Consequences of angiogenesis for tumor progression, metastasis and
cancer therapy. Anticancer Drugs. 6:3–18. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Folkman J: What is the evidence that
tumors are angiogenesis dependent? J Natl Cancer Inst. 82:4–6.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Weidner N, Folkma J, Pozza F, Bevilacqua
P, Allred EN, Moore DH, Meli S and Gasparini G: Tumor angiogenesis:
A new significant and independent prognostic indicator in
early-stage breast carcinoma. J Natl Cancer Inst. 84:1875–1887.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Flecher CD, Unni KK and Merten F: World
Health Organization classification of tumousPathology and genetics
of tumors of soft tissue and bone. IARC Press; Lyon: pp. 2–10.
2002
|
|
16
|
Carmeliet P and Jain RK: Angiogenesis in
cancer and other diseases. Nature. 407:249–257. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fukumura D, Duda DG, Munn LL and Jain RK:
Tumor microvasculature and microenvironment: Novel insights through
intravital imaging in pre-clinical models. Microcirculation.
17:206–225. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rak JW, St Croix BD and Kerbel RS:
Consequences of angiogenesis for tumor progression, metastasis and
cancer therapy. Anticancer Drugs. 6:3–18. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bose S, Lesser ML, Norton L and Rosen PP:
Immunophenotype of intraductal carcinoma. Arch Pathol Lab Med.
120:81–85. 1996.PubMed/NCBI
|
|
20
|
Gilles R, Zafrani B, Guinebretière JM,
Meunier M, Lucidarme O, Tardivon AA, Rochard F, Vanel D,
Neuenschwander S and Arriagada R: Ductal carcinoma in situ: MR
imaging-histopathologic correlation. Radiology. 196:415–419. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Schlemmer HP, Merkle J, Grobholz R, Jaeger
T, Michel MS, Werner A, Rabe J and van Kaick G: Can pre-operative
contrast-enhanced dynamic MR imaging for prostate cancer predict
microvessel density in prostatectomy specimens? Eur Radiol.
14:309–317. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Marković O, Marisavljević D, Cemerikić V,
Vidović A, Perunicić M, Todorović M, Elezović I and Colović M:
Expression of VEGF and microvessel density in patients with
multiple myeloma: Clinical and prognostic significance. Med Oncol.
25:451–457. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Luczynska E, Gasinska A, Blencharz P,
Stelmach A, Jereczek-Fossa BA and Reinfuss M: Value of perfusion CT
parameters, microvessl density and VEGF expression in
differentiation of benign and malignant prostate tumours. Pol J
Pathol. 65:229–236. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tozer GM: Measuring tumour vascular
response to antivascular and antiangiogenic drugs. Br J Radiol.
76:S23–S35. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li Y, Yang ZG, Chen TW, Chen HJ, Sun JY
and Lu YR: Peripheral lung carcinoma: Correlation of angiogenesis
and first-pass perfusion parameters of 64-detector row CT. Lung
Cancer. 61:44–53. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gordon Y, Partovi S, Müller-Eschner M,
Amarteifio E, Bäuerle T, Weber MA, Kauczor HU and Rengier F:
Dynamic contrast-enhanced magnetic resonance imaging: Fundamentals
and application to the evaluation of the peripheral perfusion.
Cardiovasc Diagn Ther. 4:147–164. 2014.PubMed/NCBI
|
|
27
|
Loizides A, Peer S, Plaikner M, Djurdjevic
T and Gruber H: Perfusion pattern of musculoskeletal masses using
contrast-enhanced ultrasound: A helpful tool for characterisation?
Eur Radiol. 22:1803–1811. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wu WC, Wang J, Detre JA, Ratcliffe SJ and
Floyd TF: Transit delay and flow quantification in muscle with
continuous arterial spin labeling perfusion-MRI. J Magn Reson
Imaging. 28:445–452. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang Z, Meng Q, Gao Z, Cai H, Ye Z and Wu
H: Evaluation of angiogenesis of VX2 soft tissue tumor by arterial
spin labeling perfusion imaging. Chin J Radiol. 10:1084–1088.
2010.
|
|
30
|
Bivard A, Krishnamurthy V, Stanwell P,
Levi C, Spratt NJ, Davis S and Parsons M: Arterial spin labeling
versus bolus-tracking perfusion in hyperacute stroke. Stroke.
45:127–133. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wolf RL, Wang J, Wang S, Melhem ER,
O'Rourke DM, Judy KD and Detre JA: Grading of CNS neoplasms using
continuous arterial spin labeled perfusion MR imaging at 3 Tesla. J
Magn Reson Imaging. 22:475–482. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Koizumi S, Sakai N, Kawaji H, Takehara Y,
Yamashita S, Sakahara H, Baba S, Hiramatsu H, Sameshima T and Namba
H: Pseudo-continuous arterial spin labeling reflects vascular
density and differentiates angiomatous meningiomas from
non-angiomatous meningiomas. J Neuroonncol. 121:549–556. 2015.
View Article : Google Scholar
|
